D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

RBC Capital analyst Matthew Hedberg raised the ... Momentum continues to build around new logo incentive programs, VMware replacement interest, and OEM partnerships, the firm added.

Russel Metals Inc. (TSX: RUS) announces that it has priced an offering (the "Offering") of $300 million aggregate principal amount of 4.423% senior unsecured notes due 2030 (the "Notes"). The net ...

BP said it would increase annual oil and gas spending to $10 billion and cut planned annual investment in energy transition ...

RBC Capital analyst Matthew Swanson initiated coverage with a Hold rating on Thryv Holdings (THRY – Research Report) today and set a price ...

Royal Bank of Canada CEO Dave McKay on Thursday underscored the role of artificial intelligence in fueling the top Canadian ...

When Royal Bank of Canada convenes its first investor day in seven years on Thursday, shareholders will focus on growth, as ...

RBC Capital Markets came out and announced that it has lowered its year-end S&P 500 (SP500) target along with its EPS ...

Barclays expects the S&P 500 index to be at 5,900 from 6,600, after Trump's sweeping moves roiled global financial markets ...

RBC Capital Markets came out and announced that it has lowered its year-end S&P 500 (SP500) target along with its EPS forecast as Wall Street’s benchmark average has shown noticeable signs of ...

“We believe Reckitt’s share price weakness this morning reflects investors’ concerns around NEC litigation in general, and the Whitfield case in particular,” said RBC Capital Markets.

On Friday, RBC Capital Markets analyst team upgraded Heineken NV (OTC:HEINY) shares from Sector Perform to Outperform, while also raising the price target to €92.00 from €80.00. The upgrade ...